文献速递眼底病与葡萄膜炎

内源性眼内炎中空气下深部玻璃体活检与常规前部玻璃体活检的培养阳性率比较

CULTURE POSITIVITY RATES OF DEEP VITREOUS BIOPSY UNDER AIR VIS-À-VIS CONVENTIONAL ANTERIOR VITREOUS BIOPSY IN ENDOGENOUS ENDOPHTHALMITIS.
PubMed 文献 · Retina · 2022-01-01

这项回顾性连续比较系列纳入2014年1月至2021年1月的内源性眼内炎病例,比较常规前部玻璃体活检组(140眼)与空气下深部玻璃体活检(DBA)组(44眼)的培养阳性率。DBA组培养阳性率为65.9%(29/44),常规组为30.71%(43/140);DBA是双变量(OR 4.36,95%CI 2.12-8.95,P<0.0001)和多变量分析(OR 4.02,95%CI 3.1-7.43,P<0.0001)中唯一显著的因素。DBA组视力结局更好(1.28±1.01 logMAR,20/380 vs 1.88±1.33 logMAR,20/1,500,P=0.03),且无病例发生视网膜脱离或该技术相关并发症。

要点

  • DBA组培养阳性率65.9%(29/44)高于常规前部玻璃体活检组30.71%(43/140)。
  • DBA是培养阳性的唯一显著因素:双变量OR 4.36(95%CI 2.12-8.95,P<0.0001),多变量OR 4.02(95%CI 3.1-7.43,P<0.0001)。
  • DBA组视力结局优于常规组(1.28±1.01 logMAR,20/380 vs 1.88±1.33 logMAR,20/1,500,P=0.03),且无技术相关并发症。

核心结论

  • 在内源性眼内炎中,空气输注下可安全有效地从深部玻璃体腔取样,提高培养阳性率。

研究设计与样本

  • 回顾性、连续、比较系列,纳入2014年1月至2021年1月的内源性眼内炎病例。
  • 分为常规前部玻璃体活检组(140眼)和空气下深部玻璃体活检(DBA)组(44眼)。
  • 比较两组培养阳性率,并通过回归分析分析影响因素。

主要发现

  • 常规前部玻璃体活检组培养阳性43/140例样本(30.71%),DBA组29/44例样本(65.9%)。
  • DBA组视力结局优于常规组:1.28±1.01 logMAR(20/380)vs 1.88±1.33 logMAR(20/1,500),P=0.03。
  • DBA组无病例发生视网膜脱离或该技术相关并发症。
  • DBA是双变量分析(OR 4.36,95%CI 2.12-8.95,P<0.0001)和多变量分析(OR 4.02,95%CI 3.1-7.43,P<0.0001)中唯一显著的因素。
  • 两组性别、年龄、症状持续时间、基础系统性疾病、就诊视力(logMAR)和玻璃体干预总次数具有可比性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe the comparison of the culture positivity rates of deep vitreous biopsy under air and conventional anterior vitreous biopsy in endogenous endophthalmitis. MATERIALS: A retrospective, consecutive, comparative series including cases of endogenous endophthalmitis from January 2014 to January 2021. They were divided into those where conventional anterior vitreous biopsy was taken and those where a deep biopsy was taken under air (DBA group). The culture positivity rate among the two groups was compared, and factors affecting the same were analyzed by a regression analysis. RESULTS: There were 140 eyes in the conventional anterior vitreous biopsy group and 44 eyes in the DBA group. Sex, age, duration of symptoms, underlying systemic illness, presenting vision in logMAR, and total number of vitreous interventions were comparable between the two groups. Visual outcome was better in patients undergoing DBA as compared with those who underwent conventional anterior vitreous biopsy , (1.28 ± 1.01 logMAR, 20/380 vs. 1.88 ± 1.33 logMAR, 20/1,500, P = 0.03). No case in the DBA group developed retinal detachment or any complication attributable to the technique. In the conventional anterior vitreous biopsy group, the culture positivity was seen in 43/140 samples (30.71%), and in the DBA group, it was noted in 29/44 samples (65.9%). Taking a DBA was the only factor that was significant both in bivariate (odds ratio 4.36, 95% confidence interval 2.12-8.95, P < 0.0001) and multivariate analysis (odds ratio 4.02, 95% confidence interval 3.1-7.43, P < 0.0001). CONCLUSION: Vitreous sampling can be performed from the deep vitreous cavity in endogenous endophthalmitis safely and effectively under air infusion, improving the culture positivity rates.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Dave VP, Vithalani N, Sheba E, et al. CULTURE POSITIVITY RATES OF DEEP VITREOUS BIOPSY UNDER AIR VIS-À-VIS CONVENTIONAL ANTERIOR VITREOUS BIOPSY IN ENDOGENOUS ENDOPHTHALMITIS. Retina. 2022. PMID: 35858281. doi:10.1097/IAE.0000000000003570

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。